Athenex's Unattributed VC - III Round

Athenex raised a round of funding on April 25, 2011.

Athenex (NASDAQ: ATNX), formerly Kinex Pharmaceuticals, is a global oncology pharmaceutical company focused on the development and commercialization of next generation therapies for cancer diseases an…

Articles about Athenex's Unattributed VC - III Round: